Company Filing History:
Years Active: 1997-1999
Title: Innovations of Said Mohamed Elgendy
Introduction
Said Mohamed Elgendy is a notable inventor based in London, GB. He has made significant contributions to the field of biochemistry, particularly in the development of thrombin inhibitors and substrates. With a total of 3 patents, his work has implications for medical research and therapeutic applications.
Latest Patents
Elgendy's latest patents focus on inhibitors and substrates of thrombin. One of his inventions provides peptides of a specific formula, wherein X can be H, CH₃, or an N-protecting group. Another patent details peptides that act as inhibitors or substrates of thrombin, derived from the formula: D-Phe-Pro-Arg or its analogues. These peptides are designed to interact with various chemical groups, enhancing their effectiveness in medical applications.
Career Highlights
Throughout his career, Elgendy has worked with esteemed organizations such as the Thrombosis Research Institute and Trigen GmbH. His experience in these institutions has allowed him to collaborate on groundbreaking research in the field of thrombin-related studies.
Collaborations
Some of his notable coworkers include John Joseph Deadman and Vijay Vir Kakkar. Their collective expertise has contributed to advancements in thrombin research and the development of innovative therapeutic solutions.
Conclusion
Said Mohamed Elgendy is a prominent inventor whose work in thrombin inhibitors and substrates has the potential to impact medical science significantly. His contributions and collaborations highlight the importance of innovation in the field of biochemistry.